VeriMomretinoyl pentapeptide-4 hamilelikte güvenli mi?
No evidence in EU Cosmetics Annex II/III or harmonised CLP of reproductive hazards for palmitoyl pentapeptide‑4; regulatory/industry sources and ingredient databases list it as a signal peptide (Matrixyl) with no reproductive or teratogenic classification. Topical peptides have low but measurable dermal absorption, and palmitoyl conjugation increases lipophilicity and skin penetration modestly, so exposure is low but measurable in adults. Sources: EWG ingredient page; ingredient summaries (Paula's Choice) and peptide safety overview (CIR pentapeptides review).
Related ingredients
Frequently asked questions
- retinoyl pentapeptide-4 hamilelikte güvenli mi?
- No evidence in EU Cosmetics Annex II/III or harmonised CLP of reproductive hazards for palmitoyl pentapeptide‑4; regulatory/industry sources and ingredient databases list it as a signal peptide (Matrixyl) with no reproductive or teratogenic classification. Topical peptides have low but measurable dermal absorption, and palmitoyl conjugation increases lipophilicity and skin penetration modestly, so exposure is low but measurable in adults. Sources: EWG ingredient page; ingredient summaries (Paula's Choice) and peptide safety overview (CIR pentapeptides review).
- retinoyl pentapeptide-4 emzirirken güvenli mi?
- Same rationale as pregnancy: no CMR or reproductive classifications and no published animal/human developmental or lactation toxicity for palmitoyl pentapeptide‑4. Topical exposure to parent peptide is low but measurable; transfer into breastmilk not reported. Evidence absence supports low hazard. (See same sources.)
- retinoyl pentapeptide-4 bebek cildi için güvenli mi?
- No infant‑specific developmental or toxicity data were found. Because infant/young‑child skin has higher absorption (higher surface‑area:weight and immature barrier), increase exposure score by +1 over adult (adult e=1 → infant e=2). No data indicate increased hazard or specific mechanisms affecting development or endocrine systems for this peptide. Sources: peptide safety reviews and product/INCI descriptions.
- VeriMom retinoyl pentapeptide-4 nasıl puanlıyor?
- VeriMom retinoyl pentapeptide-4'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte retinoyl pentapeptide-4 yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.